REDDING,
Calif., May 16, 2024 /PRNewswire/ -- According to
a new market research report titled, 'Newborn Screening
Market Size, Share, Forecast, & Trends Analysis by
Technology (Tandem Mass Spectrometry, Pulse Oximeter, Molecular
Assay, Immune Assay) Application (CHD, Infectious Diseases, Hearing
Disorder) Product, End User – Global Forecast to
2031,' published by Meticulous
Research®, newborn screening market is projected to
reach $2.69 billion by 2031, at a
CAGR of 7.8% from 2024 to 2031.
Download Sample Report Now-
https://www.meticulousresearch.com/download-sample-report/cp_id=5367
Newborn screening is a screening program for infants under which
pre-symptomatic congenital conditions are detected so that
treatment can be commenced as soon as possible to prevent or reduce
the long-term consequences of the disease. These programs are
usually run by the national or state governing bodies with the aim
of screening all infants for a defined panel of disorders that are
treatable. These tests include hearing, blood, pulse oximetry, and
other similar tests and benefit the newborn to grow normally in the
later stages of life.
The rising prevalence of congenital heart diseases and genetic
diseases, increasing neonatal population, and rising awareness
regarding newborn screening are the factors driving the growth of
the newborn screening market. Factors such as government programs
& legislation promoting newborn screening and emerging
economies are a few opportunities that would help grow the market
in the future.
Increasing Education and Awareness for Newborn
Screening
Newborn screening is being recognized by governments of various
countries worldwide due to the high prevalence of genetic and/or
metabolic conditions in newborns. Owing to the increasing
importance of newborn screening in identifying infants at risk of
diseases and aiding in timely diagnosis and management, various
countries have made newborn screening tests compulsory. For
instance, the U.S. government has made newborn screening compulsory
soon after birth. Since the 1960s, NBS programs have become the
most effective health programs in the U.S., which test for 31 of 35
core conditions recommended by the Uniform Screening Panel (RUSP).
It is estimated that around 4 million babies are screened annually
for rare and serious disorders present at birth in the U.S.
Get a Glimpse Inside: Request Sample Pages-
https://www.meticulousresearch.com/request-sample-report/cp_id=5367
Collaborations are also being carried out between public and
private organizations for newborn screening. For instance,
PerkinElmer, Inc. (U.S.) collaborated with the International
Society for Neonatal Screening (ISNS) to bring attention to
India's National Policy for Rare
Diseases 2021 and discuss strategies to improve newborn and
maternal health. The Government of India and PerkinElmer, Inc. (U.S.) also
collaborated on genetic testing and newborn screening training.
The global newborn screening market is segmented by Product
(instruments and consumables), Technology (immune assays &
enzymatic assays, tandem mass spectrometry, molecular assays,
hearing screening technologies, pulse oximetry, and other
technologies), Application (congenital heart disease, inherited
disorders {metabolic disorders, endocrine disorders, hemoglobin
disorders, and other inherited disorders}, infectious diseases,
hearing disorders, and other applications), End User (hospitals and
reference laboratories) and Geography. The study also evaluates
industry competitors and analyzes their market share at global and
regional levels.
Among products, in 2024, the consumables segment is expected to
account for the largest share of 44.2% of the newborn
screening market. The factors attributed to the large market share
of this segment include increased screening rate globally,
recurrent use of consumables, and recent kit launches for newborn
screening.
Among technologies, in 2024, the tandem mass spectrometry
segment is expected to account for the large market share of the
newborn screening market. The large share of the segment is
attributed to factors such as rapid diagnosis, increasing
prevalence of genetic diseases, increasing demand for specialists,
and increasing awareness of newborn screening.
Have Specific Research Needs? Request a Customized
Report-
https://www.meticulousresearch.com/request-customization/cp_id=5367
Among applications, in 2024, the inherited disorders segment is
expected to account for the large market share of 29.6% of
the newborn screening market. Inherited disorders are a type of
genetic disorder that are passed from parent to child. The high
incidence rate of genetic disorders among newborn babies is a key
factor attributing to the large market share of this segment. For
instance, according to the CDC, around 6,000 babies in the U.S. are
born with Down syndrome every year.
Among end users, in 2024, the hospitals segment is expected to
account for the large market share of the newborn screening market.
Advanced healthcare infrastructure, the availability of skilled
professionals, and the increasing number of childbirths in
hospitals contribute to the large market share of this segment.
Geographically, in 2024, North
America is expected to account for the largest share of
48.3% of the newborn screening market, followed by
Europe, Asia-Pacific, Latin
America, and the Middle
East & Africa. The
North America newborn screening
market is estimated to be worth USD 763
million in 2024.
However, the Asia-Pacific
newborn screening market is slated to register the highest CAGR
during the forecast period. The high market growth in Asia-Pacific is attributed to high fertility
rates in the region, improving healthcare infrastructure, and
increasing disposable income. In 2020, the fertility rates in
India and China were 2.2 and 1.8, respectively.
Additionally, government initiatives and growing awareness in the
region about newborn screening and its advantages, and rising
healthcare expenditure are likely to boost the newborn screening
market in Asia-Pacific.
The report also includes an extensive assessment of the key
strategic developments of leading market participants in the
industry over the past three years (2020–2024). The global newborn
screening market has witnessed product launches, collaborations,
agreements, and expansions in the last couple of years.
Some of the key players operating in the global newborn
screening market are Thermo Fisher Scientific, Inc. (U.S.),
ARCHIMED Group (France),
PerkinElmer, Inc. (U.S.), Medtronic plc (Ireland), Trivitron Healthcare Pvt Ltd.
(India), Bio-Rad Laboratories,
Inc. (U.S.), Demant A/S (Denmark),
Baebies, Inc. (U.S.), ZenTech s.a. (Belgium), and F. Hoffmann-La Roche AG
(Switzerland).
Brows In-depth Report Now-
https://www.meticulousresearch.com/product/newborn-screening-market-5367
Scope of the Report:
Newborn Screening Market Assessment–by Product
Newborn Screening Market Assessment–by Technology
- Immune Assays & Enzymatic Assays
- Tandem Mass Spectrometry
- Molecular Assays
- Hearing Screening Technologies
- Pulse Oximetry
- Other Technologies
Note: Other technologies include gel electrophoresis,
hematology, microbiology, and urinalysis.
Newborn Screening Market Assessment–by Application
- Congenital Heart Disease
- Inherited Disorders
- Metabolic Disorders
- Endocrine Disorders
- Hemoglobin Disorders
- Other Inherited Disorders
- Infectious diseases
- Hearing Disorders
- Other Applications
Note: Other inherited disorders include galactosemia,
biotinidase deficiency, cystic fibrosis, severe combined
immunodeficiency (SCID), Pompe disease (glycogen storage disease
type II), mucopolysaccharidosis type 1, X-linked
adrenoleukodystrophy, and spinal muscle atrophy (SMA).
Note: Other applications include birth injuries, birth
trauma, and malformation.
Newborn Screening Market Assessment–by End User
- Hospitals
- Reference Laboratories
Newborn Screening Market Assessment–by Geography
- North America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Rest of Europe (RoE)
- Asia-Pacific (APAC)
- China
- Japan
- India
- Rest of APAC (RoAPAC)
- Latin America
- Brazil
- Mexico
- Rest of Latin America
(RoLATM)
- Middle East & Africa
Unlock Opportunities: Buy
Now- https://www.meticulousresearch.com/Checkout/52341509
Related Reports:
Non-Invasive Prenatal Testing (NIPT) Market by Product and
Solution (Consumables, Systems, Software), Method (Ultrasound
Screening, Cell Free DNA Test), Application (Trisomy,
Microdeletions, Monosomy), and End-user (Diagnostic Labs) - Global
Forecast to 2027
Next Generation Sequencing Market by Type (Consumables, NGS
Platform, Software), Sequencing Type (Whole Genome, Targeted),
Technology (Sequencing by Synthesis, Sequencing by Ligation),
Application (Clinical, Research), End User - Global Forecasts to
2025
Point of Care Molecular Diagnostics Market by Product and
Solution (Assay, Analyzer, Software, Services), Technology
(RT-qPCR, INAAT), Application (Respiratory Diseases, Hospital
Acquired Infections, STD), and End User - Global Forecast to
2027
Related Blogs:
Top 10 Companies in Newborn Screening Market
The Importance of Newborn Screening: Ensuring Early Detection of
Genetic Disorders
About Meticulous Research®
Meticulous Research® was founded in 2010 and incorporated as
Meticulous Market Research Pvt. Ltd. in 2013 as a private limited
company under the Companies Act, 1956. Since its incorporation, the
company has become the leading provider of premium market
intelligence in North America,
Europe, Asia-Pacific, Latin
America, and the Middle
East & Africa.
The name of our company defines our services, strengths, and
values. Since the inception, we have only thrived to research,
analyze, and present the critical market data with great attention
to details. With the meticulous primary and secondary research
techniques, we have built strong capabilities in data collection,
interpretation, and analysis of data including qualitative and
quantitative research with the finest team of analysts. We design
our meticulously analyzed intelligent and value-driven syndicate
market research reports, custom studies, quick turnaround research,
and consulting solutions to address business challenges of
sustainable growth.
Contact:
Mr. Khushal
Bombe
Meticulous Market Research Inc.
1267 Willis St, Ste 200 Redding,
California, 96001, U.S.
USA: +1-646-781-8004
Europe : +44-203-868-8738
APAC: +91 744-7780008
Email- sales@meticulousresearch.com
Visit Our Website: https://www.meticulousresearch.com/
Connect with us on LinkedIn-
https://www.linkedin.com/company/meticulous-research
Content Source:
https://www.meticulousresearch.com/pressrelease/594/newborn-screening-market-2031
Logo:
https://mma.prnewswire.com/media/1757980/Meticulous_Research_Logo_1.jpg
View original
content:https://www.prnewswire.com/news-releases/newborn-screening-market-to-be-worth-2-69-billion-by-2031---exclusive-report-by-meticulous-research-302147765.html
SOURCE Meticulous Market Research Pvt. Ltd.